Malaysia General Pharmaceuticals Research
9 comprehensive market analysis studies and research reports on the Malaysia General Pharmaceuticals sector, offering an overview with historical data since 2019 and forecasts up to 2030. This includes a detailed market research of 1007 companies, enriched with industry statistics, insights, and a lot more.
TRENDING REPORTS
Skin Antiseptic Products Market
CAGR: 6.34%
Study Period: 2020 - 2031
Penicillin Drug Market
CAGR: 3.41%
Study Period: 2020 - 2031
Insulin Market
CAGR: 3.62%
Study Period: 2020 - 2031
Anesthesia Drugs Market
CAGR: 3.65%
Study Period: 2020 - 2031
Antivenom Market
CAGR: 3.13%
Study Period: 2020 - 2031
Healthcare
Categories
9 Healthcare Reports
Categories
Showing 9 of 9 results in General Pharmaceuticals
Asia-Pacific Alpha-Glucosidase Inhibitors Market
CAGR: 2.30%
Study Period: 2019 - 2030
Starting at:$4,750
Country Covered: Malaysia
Major Players:Takeda Pharmaceuticals, Pfizer, Bayer, Sun Pharmaceuticals Industries, Glenmark Pharmaceuticals
Starting at:$4,750
APAC Meglitinide Market
CAGR: 1.7%
Study Period: 2019 - 2030
Starting at:$4,750
Country Covered: Malaysia
Major Players:Novo Nordisk, Glenmark Pharmaceuticals, Novartis, KISSEI PHARMACEUTICAL, Biocon
Starting at:$4,750
APAC Biguanide Market
CAGR: 2%
Study Period: 2019 - 2030
Starting at:$4,750
Country Covered: Malaysia
Major Players:Takeda Pharmaceuticals, Bristol-Myers Squibb, Glenmark Pharmaceuticals, Merck, Sanofi
Starting at:$4,750
Sulfonylureas Market
CAGR: 3.12%
Study Period: 2019 - 2030
Starting at:$4,750
Country Covered: Malaysia
Major Players:Sanofi, Pfizer, Merck, Torrent Pharmaceuticals, Dr. Reddy’s Laboratories
Starting at:$4,750
Meglitinide Market
CAGR: 2.21%
Study Period: 2019 - 2030
Starting at:$4,750
Country Covered: Malaysia
Major Players:Glenmark Pharmaceuticals, Novartis, KISSEI PHARMACEUTICAL, Biocon, Novo Nordisk
Starting at:$4,750
Alpha-glucosidase Inhibitors Market
CAGR: 2.17%
Study Period: 2019 - 2030
Starting at:$4,750
Country Covered: Malaysia
Major Players:Sun Pharmaceuticals Industries, Bayer, Takeda Pharmaceuticals, Torrent Pharmaceuticals, Pfizer
Starting at:$4,750
Asia-Pacific Sodium-dependent Glucose Cotransporter 2 Market
CAGR: 7.94%
Study Period: 2020 - 2031
Starting at:$4,750
Country Covered: Malaysia
Major Players:Eli Lilly and Company, Boehringer Ingelheim, Janssen, AstraZeneca, Bristol-Myers Squibb
Starting at:$4,750
Asia-Pacific Glucagon-like Peptide-1 (GLP-1) Agonists Market
CAGR: 5.38%
Study Period: 2019 - 2030
Starting at:$4,750
Country Covered: Malaysia
Major Players:AstraZeneca, Eli Lilly and Company, Novo Nordisk, Sanofi, Biocon
Starting at:$4,750
Asia-Pacific Insulin Therapeutics Market
CAGR: 2.54%
Study Period: 2019 - 2030
Starting at:$4,750
Country Covered: Malaysia
Major Players:Novo Nordisk, Eli Lilly and Company, Sanofi, Biocon, Gan & Lee
Starting at:$4,750
CONTACT US
When decisions matter, industry leaders turn to our analysts. Let’s talk.